This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keppler, O T Articles by Pawlita, M Search for Related Content PubMed PubMed Citation Articles by Keppler, O T Articles by Pawlita, M

 Previous Article  |  Next Article 

J Virol. 1994 November; 68(11): 6933-6939

Regulation of susceptibility and cell surface receptor for the B-lymphotropic papovavirus by N glycosylation.

Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

ABSTRACT

The host range of the B-lymphotropic papovavirus (LPV) in cultured human cells is limited to a few B-lymphoma-derived cell lines. The constitutively expressed cell surface receptor for the virus is a major determinant restricting the LPV host range (G. Haun, O. T. Keppler, C. T. Bock, M. Herrmann, H. Zentgraf, and M. Pawlita, J. Virol. 67:7482-7492, 1993). Here we show that human B-lymphoma cells with low-level susceptibility are rendered highly susceptible to LPV infection by pretreatment with the N glycosylation inhibitor tunicamycin but remain nonsusceptible to infection by the related polyomavirus simian virus 40. Among the selective N glycosylation processing inhibitors, deoxymannojirimycin, but not deoxynojirimycin, swainsonine, or castanospermine, could mimic the effect of tunicamycin. Tunicamycin treatment also induced a drastic enhancement of the cells' LPV-binding capacity, indicating that the induction of LPV susceptibility might be mediated by an increase in the number of functional cell surface receptors and/or by increased receptor affinity. Sialidase sensitivity of the tunicamycin-induced LPV receptor showed that oligosaccharides carrying terminal sialic acids are necessary for binding and are likely to be O linked. The constitutive LPV receptor is also sialic acid dependent, which points to a possible identity with the sialic acid-dependent tunicamycin-induced LPV receptor. We conclude that removal or modification of certain N-linked oligosaccharides in human B-lymphoma cells can enhance expression or functional activity of the sialylated LPV receptor.

This article has been cited by other articles:

• Oetke, C., Brossmer, R., Mantey, L. R., Hinderlich, S., Isecke, R., Reutter, W., Keppler, O. T., Pawlita, M. (2002). Versatile Biosynthetic Engineering of Sialic Acid in Living Cells Using Synthetic Sialic Acid Analogues. J. Biol. Chem. 277: 6688-6695 [Abstract] [Full Text]  
• Wentworth, D. E., Holmes, K. V. (2001). Molecular Determinants of Species Specificity in the Coronavirus Receptor Aminopeptidase N (CD13): Influence of N-Linked Glycosylation. J. Virol. 75: 9741-9752 [Abstract] [Full Text]  
• Guerrero, C. A., Zárate, S., Corkidi, G., López, S., Arias, C. F. (2000). Biochemical Characterization of Rotavirus Receptors in MA104 Cells. J. Virol. 74: 9362-9371 [Abstract] [Full Text]  
• Hamilton, R. S., Gravell, M., Major, E. O. (2000). Comparison of Antibody Titers Determined by Hemagglutination Inhibition and Enzyme Immunoassay for JC Virus and BK Virus. J. Clin. Microbiol. 38: 105-109 [Abstract] [Full Text]  
• Liu, C. K., Wei, G., Atwood, W. J. (1998). Infection of Glial Cells by the Human Polyomavirus JC Is Mediated by an N-Linked Glycoprotein Containing Terminal alpha (2-6)-Linked Sialic Acids. J. Virol. 72: 4643-4649 [Abstract] [Full Text]